Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMD vs GSK✓SelectedUSD · GSKAMD vs GSK performance historyLatest closeAs of-8.75%11/13
Stock and ETF performance explorer

AMD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+357.3%
GSK return
+65.8%
Excess return
+291.5%
Maximum drawdown
-63.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-8.8%+0.5%-9.3%-8.7%
7D+18.9%+1.1%+17.8%+19.1%
30D-6.4%+6.3%-12.8%-5.5%
3M+10.6%+1.8%+8.8%+11.3%
6M+19.9%+1.7%+18.2%+20.6%
YTD+149.4%+6.5%+142.8%+150.3%
1Y+115.4%+9.5%+105.9%+116.0%
3Y+357.3%+65.3%+292.0%+401.5%
All+357.3%+65.8%+291.5%+401.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling